A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation
The social profile of reluctant responders is even more worrying: this attitude was more prevalent among low-income people (37%), who are generally more exposed to infectious diseases,4 among young women (aged 18–35 years; 36%), who play a crucial role regarding childhood vaccination,5 and among peo...
Saved in:
Published in | The Lancet infectious diseases Vol. 20; no. 7; pp. 769 - 770 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Ltd
01.07.2020
Elsevier Limited New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001 |
Subjects | |
Online Access | Get full text |
ISSN | 1473-3099 1474-4457 1474-4457 |
DOI | 10.1016/S1473-3099(20)30426-6 |
Cover
Summary: | The social profile of reluctant responders is even more worrying: this attitude was more prevalent among low-income people (37%), who are generally more exposed to infectious diseases,4 among young women (aged 18–35 years; 36%), who play a crucial role regarding childhood vaccination,5 and among people aged older than 75 years (22%), who are probably at an increased risk for severe illness from COVID-19. When this dimension has been studied, researchers have often found a connection between political beliefs and attitudes to vaccines.6 They highlight a crucial issue for public health interventions: how can we assure the public that recommendations reflect the state of scientific knowledge rather than political interests? Public authorities are setting up fast-track approval processes for a putative vaccine against SARS-CoV-2.9 It is crucial to communicate early and transparently on these processes to avoid vaccines becoming part of political debates. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Commentary-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 PMCID: PMC7239623 The COCONEL Group includes: Patrick Peretti-Watel (scientific coordinator), Valérie Seror, Sébastien Cortaredona, Odile Launay, Jocelyn Raude, Pierre Verger (research consortium), François Beck, Stéphane Legleye, Olivier L'Haridon, Jeremy Ward (steering committee) Aix Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France (PP-W, VS, SC, JW); Southeastern Health Regional Observatory (ORS Paca), Marseille, France (PP-W, PV); Inserm CIC 1417, Université Paris, Faculté de Médecine Paris Descartes, AP-HP, Hôpital Cochin, Paris, France (OL); EHESP School of Public Health, Rennes, France (JR); CESP, Université Paris Sud, Faculté de Médecine UVSQ, Inserm, Université Paris-Saclay, Villejuif, France (FB, SL); Université Rennes, CNRS, CREM UMR 6211, Rennes, France (OL'H); and GEMASS, CNRS, Université Paris Sorbonne, Paris, France (JW) |
ISSN: | 1473-3099 1474-4457 1474-4457 |
DOI: | 10.1016/S1473-3099(20)30426-6 |